Pension & Wealth Management Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-89
Closed -$3.46K – 594
2025
Q3
$3.46K Hold
89
– – ﹤0.01% 454
2025
Q2
$2.68K Hold
89
– – ﹤0.01% 420
2025
Q1
$2.54K Sell
89
-167
-65% -$5.28K ﹤0.01% 409
2024
Q4
$8.46K Hold
256
– – ﹤0.01% 376
2024
Q3
$9.56K Hold
256
– – ﹤0.01% 300
2024
Q2
$8.6K Hold
256
– – ﹤0.01% 289
2024
Q1
$9.15K Sell
256
-37
-13% -$1.28K 0.01% 281
2023
Q4
$9.65K Buy
293
+186
+174% +$4.99K 0.01% 251
2023
Q3
$2.91K Hold
107
– – ﹤0.01% 237
2023
Q2
$3.38K Hold
107
– – ﹤0.01% 237
2023
Q1
$2.91K Hold
107
– – ﹤0.01% 265
2022
Q4
$3.25K Buy
+107
New +$3.22K ﹤0.01% 230

Other funds holding SBIO

Pension & Wealth Management Advisors's SBIO Position: Q4 2025 in Review

Pension & Wealth Management Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2025, closing a stake of 89 shares — an estimated $3.46K sold.

Pension & Wealth Management Advisors first reported a position in SBIO in Q4 2022 and held it in 12 quarters. The position peaked at $9.65K in Q4 2023. 59 funds tracked by Wall St. Rank hold SBIO as of Q4 2025.

  • Pension & Wealth Management Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2025 after selling out during the quarter.
  • Pension & Wealth Management Advisors sold 89 ALPS Medical Breakthroughs ETF shares in Q4 2025, an estimated $3.46K.
  • Pension & Wealth Management Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q4 2022 and held it in 12 quarters.
  • Pension & Wealth Management Advisors's ALPS Medical Breakthroughs ETF position peaked at $9.65K in Q4 2023.
  • 59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2025.

Based on Pension & Wealth Management Advisors's 13F filing for Q4 2025, filed 7 Aug 2026.